References
1) Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018; 73:744-764.
2) Vidal C, Armisén M, Monsalve R, et al. Anaphylaxis to Vespa velutina nigrithorax : pattern of sensitization for an emerging problem in western countries. J Investig Allergol Clin Immunol. 2023; 31(3):228-235.
3) Schiavino D, Nucera E, Pollastrini E, et al. Specific ultrarush desensitization in Hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol. 2004;92(4): 409-413.
4) Sturm GJ, Schadelbauer E, Marta G, Bondaonna P, Kosnik M. Risk factors for severe sting reactions and side effects during venom immunotherapy. J Allergy Clin Immunol Pract. 2025;1381):17-23.
5) Kasternow B, Kim DS, Yong PFK. Efficacy and safety of a 7-week immunotherapy protocol with aluminum hydroxide absorberd hymenoptera venom. Allergy. 2024;79(10):2840-2842.
6) Pucci S, Ciccarelli F, De Pasquale T, Illuminati I, D’Alò S. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy. Ann Allergy Asthma Immunol. 2018;121(3):376-377.